Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spacelabs “Customer First” Approach To Continue Under OSI Ownership

This article was originally published in The Gray Sheet

Executive Summary

Spacelabs Medical will retain its customer-driven strategy for iterative changes to its patient monitors as a subsidiary of OSI Systems, according to firm President Richard Atkin

You may also be interested in...



GEMS Commitment Will Facilitate EU Clearance Of Spacelabs Purchase – OSI

OSI Systems will expand its pulse oximetry customer base and realize manufacturing synergies through the $57 mil. cash purchase of Instrumentarium unit Spacelabs Medical from GE Medical Systems

Spacelabs For Sale Under GE/Instrumentarium Conditions: Is CSI Interested?

GE Medical Systems is seeking a purchaser for Instrumentarium's Spacelabs patient monitoring business to satisfy European conditions for the firms' merger

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019988

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel